20
Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RIVASTIGMINE USP, with a corresponding US DMF Number 24502.
Remarkably, this DMF maintains an Active status since its submission on March 27, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 12, 2014, and payment made on August 07, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II